Bipolar disorder biomarkers improve diagnostic accuracy. We analyze current research, FDA approval timelines, and test costs ($500-$3K).

Bipolar disorder biomarkers improve diagnostic accuracy. We analyze current research, FDA approval timelines, and test costs ($500-$3K).